SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Schick H.) "

Sökning: WFRF:(Schick H.)

  • Resultat 1-10 av 24
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Seufferlein, T, et al. (författare)
  • [S3-guideline exocrine pancreatic cancer]
  • 2013
  • Ingår i: Zeitschrift fur Gastroenterologie. - : Georg Thieme Verlag KG. - 1439-7803 .- 0044-2771. ; 51:12, s. 1395-1440
  • Tidskriftsartikel (refereegranskat)
  •  
5.
  •  
6.
  • Kilpeläinen, Tuomas O, et al. (författare)
  • Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels
  • 2016
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 7
  • Tidskriftsartikel (refereegranskat)abstract
    • Leptin is an adipocyte-secreted hormone, the circulating levels of which correlate closely with overall adiposity. Although rare mutations in the leptin (LEP) gene are well known to cause leptin deficiency and severe obesity, no common loci regulating circulating leptin levels have been uncovered. Therefore, we performed a genome-wide association study (GWAS) of circulating leptin levels from 32,161 individuals and followed up loci reaching P<10(-6) in 19,979 additional individuals. We identify five loci robustly associated (P<5 × 10(-8)) with leptin levels in/near LEP, SLC32A1, GCKR, CCNL1 and FTO. Although the association of the FTO obesity locus with leptin levels is abolished by adjustment for BMI, associations of the four other loci are independent of adiposity. The GCKR locus was found associated with multiple metabolic traits in previous GWAS and the CCNL1 locus with birth weight. Knockdown experiments in mouse adipose tissue explants show convincing evidence for adipogenin, a regulator of adipocyte differentiation, as the novel causal gene in the SLC32A1 locus influencing leptin levels. Our findings provide novel insights into the regulation of leptin production by adipose tissue and open new avenues for examining the influence of variation in leptin levels on adiposity and metabolic health.
  •  
7.
  •  
8.
  • Biederstädt, A., et al. (författare)
  • SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
  • 2020
  • Ingår i: Gut. - : BMJ. - 0017-5749 .- 1468-3288. ; 69, s. 1472-1482
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Pancreatic ductal adenocarcinoma (PDAC) still carries a dismal prognosis with an overall 5-year survival rate of 9%. Conventional combination chemotherapies are a clear advance in the treatment of PDAC; however, subtypes of the disease exist, which exhibit extensive resistance to such therapies. Genomic MYC amplifications represent a distinct subset of PDAC with an aggressive tumour biology. It is clear that hyperactivation of MYC generates dependencies that can be exploited therapeutically. The aim of the study was to find and to target MYC-associated dependencies. Design: We analysed human PDAC gene expression datasets. Results were corroborated by the analysis of the small ubiquitin-like modifier (SUMO) pathway in a large PDAC cohort using immunohistochemistry. A SUMO inhibitor was used and characterised using human and murine two-dimensional, organoid and in vivo models of PDAC. Results: We observed that MYC is connected to the SUMOylation machinery in PDAC. Components of the SUMO pathway characterise a PDAC subtype with a dismal prognosis and we provide evidence that hyperactivation of MYC is connected to an increased sensitivity to pharmacological SUMO inhibition. Conclusion: SUMO inhibitor-based therapies should be further developed for an aggressive PDAC subtype. © 2020 American Medical Association. All rights reserved.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 24
Typ av publikation
tidskriftsartikel (24)
Typ av innehåll
refereegranskat (23)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Metspalu, Andres (5)
Loos, Ruth J F (5)
Melander, Olle (4)
Deloukas, Panos (4)
Franks, Paul W. (4)
Wareham, Nicholas J. (4)
visa fler...
Auer, Paul L. (4)
Orho-Melander, Marju (4)
Scott, Robert A (4)
Kathiresan, Sekar (4)
Reiner, Alex P. (4)
Li, X. (3)
Willemsen, G (3)
Fereshtehnejad, SM (3)
Langenberg, C. (3)
Tanaka, T. (3)
Raitakari, Olli T (3)
Teumer, A (3)
Ferrucci, L (3)
Gudnason, V (3)
Hofman, A (3)
Sattar, Naveed (3)
McCarthy, Mark I (3)
Boerwinkle, E (3)
Chasman, Daniel I. (3)
Kraft, P (3)
Campbell, H (3)
Peters, Annette (3)
Strauch, Konstantin (3)
Samani, Nilesh J. (3)
Sijbrandij, M (3)
Mahajan, Anubha (3)
Peloso, Gina M. (3)
Deary, Ian J (3)
Hayward, C. (3)
Rivadeneira, Fernand ... (3)
Mihailov, E (3)
Harris, Tamara B (3)
Liu, Yongmei (3)
Hofman, Albert (3)
Uitterlinden, André ... (3)
Hayward, Caroline (3)
Vuckovic, D (3)
Tardif, Jean-Claude (3)
Lange, Leslie A. (3)
Boerwinkle, Eric (3)
Schunkert, Heribert (3)
Wilson, James G. (3)
Erdmann, Jeanette (3)
Meisinger, Christa (3)
visa färre...
Lärosäte
Karolinska Institutet (13)
Lunds universitet (7)
Uppsala universitet (6)
Umeå universitet (4)
Göteborgs universitet (3)
Mittuniversitetet (3)
visa fler...
Kungliga Tekniska Högskolan (1)
Stockholms universitet (1)
visa färre...
Språk
Engelska (24)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (12)
Naturvetenskap (2)
Lantbruksvetenskap (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy